Associate ProfessorSudarshini Ramanathan
NHMRC Principal Research Fellow & L3 Supervisor
Faculty of Medicine and Health
- NHMRC Principal Research Fellow & L3 SupervisorFaculty of Medicine and Health
Research projects & supervision summary
Project Opportunities
Title: Defining the clinical and immunogenetic profile in antibody-associated demyelination
Summary of opportunity:
Masters or PhD opportunity ideally suited for a medical or neurology trainee or fellow with a commitment to building expertise in clinical and translational neuroimmunology.
Opportunity synopsis:
Neuroimmunology is a rapidly evolving and exciting field - in recent years there has been significant momentum in identifying patients with antibodies targeting certain antigenic targets in the central nervous system, which results in inflammatory damage of the optic nerve, spinal cord, and brain. Some of these antibodies result in demyelination and serve as critical biomarkers to distinguish these patients from those with multiple sclerosis, which responds to different treatments. Our group has been an international leader in the clinical and immunological characterization of patients with antibodies targeting myelin oligodendrocyte glycoprotein (MOG). MOG antibody-associated demyelination is now established as an under-recognized condition which can result in lasting disability including blindness and paralysis. However, early detection and effective treatment with immunotherapy can allow patients to return to their normal function and quality of life, rendering it a compelling focus for research.Our research team initiated and leads the Australian and New Zealand MOG Study Group, a national multicenter collaboration of over 150 neurologists from over 45 centres in Australasia; and is responsible for one of the largest international cohorts of patients with MOG antibody-associated demyelination including approximately 300 adults and 200 children. The student undertaking this project will perform detailed analysis of patients in this cohort with a focus on the clinical, radiological, immunogenetic, and therapeutic characterization of this disorder. The student will further be a key player in a national multicenter epidemiological study we will lead in antibody-associated demyelination, and have additional opportunities to build laboratory experience in neuroimmunology. Funding opportunities and support are available. This project will be ideally suited as a PhD for a neurology advanced trainee or fellow with a commitment to building expertise in neuroimmunology.
RESEARCH PROJECTS & ACTIVITIES
- RESEARCH-BASED DEGREE SUPERVISIONCharacterising a Clinical and Laboratory Patient Profile that Predicts Relapse in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
- RESEARCH-BASED DEGREE SUPERVISIONClinical and immunological biomarker profiling to improve the diagnosis of acute uveitis
- RESEARCH-BASED DEGREE SUPERVISIONClinical, radiological, therapeutic and prognostic characterisation of Susac Syndrome (SuS) in an Australian Cohort
- RESEARCH-BASED DEGREE SUPERVISIONDefining Diagnostic and Prognostic Markers in Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disorders
- RESEARCH-BASED DEGREE SUPERVISIONDefining diagnostic and therapeutic guidelines in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
- RESEARCH-BASED DEGREE SUPERVISIONDefining the Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein Antibody Disease
- RESEARCH-BASED DEGREE SUPERVISIONEvaluating the diagnostic standards of care for patients with myasthenia gravis
- RESEARCH-BASED DEGREE SUPERVISIONImmunomodulatory Nanotherapeutics in the Treatment of Autoimmune Diseases in the Central Nervous System
- RESEARCH-BASED DEGREE SUPERVISIONOPTIMISING THE ACCURACY AND ACCESSIBILITY OF DIAGNOSIS AND IMMUNOTHERAPY TO IMPROVE PROGNOSIS IN MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE